Medication info
Aprovasc Tablet 150/5 mg (Irbesartan, Amlodipine Besilate)

Aprovasc Tablet 150/5 mg (Irbesartan, Amlodipine Besilate)

Prescription medicationTabletOral
Ingredient · strength
Irbesartan›150mg / 1 tabletAmlodipine Besylate›7mg / 1 tablet
Manufacturer / importer
Hanmi Pharmaceutical Co., Ltd.
Appearance
White, egg-shaped film-coated tablets
Packaging
Bottle - 100 tablets/bottle, Bottle - 30 tablets/bottle
Approval status
Active

MFDS item code 202303233 · Approved 2023.11.28 · Insurance code 652105910

Summary

Main use
Treatment of essential hypertension not controlled by irbesartan monotherapy
Who takes it
Adults
Adult dose
○ Adults Take 1 tablet once daily with water, with or without food. If possible, it is recommended that you take it at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose of irbesartan be adjusted. However, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. • 150/5 mg: For patients whose blood pressure is not adequately controlled with irbesartan 150 mg monotherapy. • 150/10 mg: For patients whose blood pressure is not adequately controlled with irbesartan 150 mg monotherapy or this medicine at 150/5 mg. • 300/5 mg: For patients whose blood pressure is not adequately controlled with irbesartan 300 mg monotherapy. Patients taking irbesartan and amlodipine as separate medicines may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. In general, blood pressure control over 24 hours is better with irbesartan 150 mg than with irbesartan 75 mg once daily. However, irbesartan 75 mg may be considered in certain cases (such as at the start of treatment, in patients on hemodialysis, or in patients aged 75 years and older). This medicine is not recommended when a reduction in the irbesartan dose (e.g., to 75 mg once daily) is required. ○ Older adults Dose adjustment is generally not necessary. However, in patients aged 75 years and older, irbesartan 75 mg should be considered as the initial dose; therefore, this medicine is not recommended for initial treatment. ○ Patients with renal impairment Dose adjustment is generally not necessary. However, in patients on hemodialysis, irbesartan 75 mg should be considered as the initial dose; therefore, this medicine is not recommended for initial treatment. ○ Patients with hepatic impairment Dose adjustment is generally not necessary in patients with mild to moderate hepatic impairment, but it is recommended that the daily dose of irbesartan not exceed 150 mg. However, there is no clinical experience with irbesartan in patients with severe hepatic impairment.

Ingredients

Manufacturer
Hanmi Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled by irbesartan monotherapy

  • Essential hypertension
View approved original text

This medication is used to control blood pressure in patients with essential hypertension whose blood pressure is not adequately controlled with irbesartan alone.

How to take

Adult dose

○ Adults Take 1 tablet once daily with water, with or without food. If possible, it is recommended that you take it at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose of irbesartan be adjusted. However, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. • 150/5 mg: For patients whose blood pressure is not adequately controlled with irbesartan 150 mg monotherapy. • 150/10 mg: For patients whose blood pressure is not adequately controlled with irbesartan 150 mg monotherapy or this medicine at 150/5 mg. • 300/5 mg: For patients whose blood pressure is not adequately controlled with irbesartan 300 mg monotherapy. Patients taking irbesartan and amlodipine as separate medicines may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. In general, blood pressure control over 24 hours is better with irbesartan 150 mg than with irbesartan 75 mg once daily. However, irbesartan 75 mg may be considered in certain cases (such as at the start of treatment, in patients on hemodialysis, or in patients aged 75 years and older). This medicine is not recommended when a reduction in the irbesartan dose (e.g., to 75 mg once daily) is required. ○ Older adults Dose adjustment is generally not necessary. However, in patients aged 75 years and older, irbesartan 75 mg should be considered as the initial dose; therefore, this medicine is not recommended for initial treatment. ○ Patients with renal impairment Dose adjustment is generally not necessary. However, in patients on hemodialysis, irbesartan 75 mg should be considered as the initial dose; therefore, this medicine is not recommended for initial treatment. ○ Patients with hepatic impairment Dose adjustment is generally not necessary in patients with mild to moderate hepatic impairment, but it is recommended that the daily dose of irbesartan not exceed 150 mg. However, there is no clinical experience with irbesartan in patients with severe hepatic impairment.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. It should not be taken by individuals with allergies to this medication or its components, pregnant or breastfeeding women, patients with severe liver impairment, or patients with a history of certain types of angioedema. Elderly patients, patients with hyperkalemia, those with liver impairment, and patients with heart or kidney issues should use this medication cautiously, and dosage adjustment may be necessary. This medication lowers blood pressure and may cause various adverse reactions such as dizziness, headache, edema, skin rash, myalgia, etc. In particular, serious side effects such as excessively low blood pressure, hyperkalemia, kidney failure, liver dysfunction, hypoglycemia, angioedema may occur, so it is essential to consult a physician if any unusual symptoms arise. This medication may interact with other antihypertensives, diuretics, potassium supplements, and certain diabetes medications, so it is crucial to inform your healthcare provider of all medications you are currently taking. It is safer not to take this medication during pregnancy or breastfeeding, and breastfeeding should be stopped if necessary. In the case of an overdose, symptoms such as hypotension, tachycardia, and shock may occur, and immediate medical assistance should be sought; self-treatment or discontinuation of the medication should not occur. Store in a safe place out of reach of children, and it is best not to transfer the tablets to another container.

Side effects

COVID-19, nasopharyngitis, constipation, upper abdominal pain, chronic gastritis, gastroesophageal reflux disease, toothache, dizziness, headache, position-related dizziness, dyslipidemia, hyperkalemia, hyperlipidemia, back pain, bursitis, muscle single contraction, dermatitis, pruritus, palpitations, Graves' disease, eyelid twitching, spinal fracture, increased blood uric acid, rhinitis, chest pain, facial edema, edema, hypertriglyceridemia, increased alanine aminotransferase, increased blood triglycerides, increased gamma-glutamyl transferase, atrial fibrillation, hypersensitivity, albuminuria, cough, urticaria, upper respiratory tract infection, sinus abnormalities, influenza, pharyngitis, musculoskeletal pain, myalgia, dizziness, fatigue, diarrhea, nausea, vomiting, musculoskeletal trauma, chest pain, dyspepsia, edema, abdominal pain, rash, tachycardia, anxiety, irritability, upper urinary tract infection, fever, chills, facial swelling, arm swelling, flushing, itching, dermatitis, petechiae, erythema, urticaria, sexual dysfunction, changes in sexual function, gout, constipation, oral lesions, gastroenteritis, abdominal distension, limb edema, muscle stiffness, arthritis, myalgia, chest pain, joint stiffness, bursitis, muscle weakness, sleep disturbances, paralysis, hypersomnia, mood disorders, depression, sensory abnormalities, tremors, transient ischemia, cerebrovascular accident, abnormal urination, prostate abnormalities, epistaxis, bronchitis, congestion, pulmonary congestion, dyspnea, wheezing, visual impairment, auditory abnormalities, ear inflammation, ear pain, conjunctivitis, eyelid abnormalities, ear abnormalities, dizziness, orthostatic dizziness, orthostatic hypotension, increased plasma creatine kinase, weakness, diarrhea, dyspepsia, nausea, tinnitus, myalgia, increased plasma creatine kinase, arthralgia, tachycardia, hepatitis, impaired liver function, renal failure, psoriasis, photosensitivity reactions, anemia, thrombocytopenia, hypoglycemia, angioedema, shock, syncope, loss of consciousness, renal failure, liver dysfunction, jaundice, rhabdomyolysis, severe hypotension, reflex tachycardia, systemic hypotension, shock state, non-cardiogenic pulmonary edema, vascular flushing, generalized fatigue, edema, palpitations, central and peripheral nervous system dizziness, headache, drowsiness, gastrointestinal abdominal pain, nausea, weakness, lethargy, pain, weight changes, hypotension, vasculitis, tension hypertension, sensory impairment, sensory abnormalities, peripheral neuropathy, syncope, taste disorders, tremors, extrapyramidal disorder, erectile dysfunction, gynecomastia, changes in bowel habits, dry mouth, dyspepsia, gingival hypertrophy, pancreatitis, vomiting, hyperglycemia, arthralgia, low back pain, muscle cramps, myalgia, leukopenia, thrombocytopenia, insomnia, mood changes, cough, dyspnea, rhinitis, alopecia, hyperhidrosis, purpura, skin discoloration, urticaria, toxic epidermal necrolysis, sounds in the ear, visual disturbances, increased urination frequency, urination disorders, nocturia, hepatitis, jaundice, elevated liver enzyme levels, skin redness and pain, maculopapular rash, myocardial infarction, arrhythmia, chest pain, hypotension, sinoatrial block, atrioventricular block, abdominal discomfort, epigastric pain, diarrhea, loose stools, constipation, heaviness, warmth, impaired glucose tolerance, weakness, intestinal vascular edema, abdominal pain, nausea, vomiting, diarrhea

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly closed container to avoid exposure to air and moisture. Maintain a storage temperature between 1 to 30 degrees Celsius at room temperature, and keep it away from direct sunlight in a dark place.

Appearance and packaging

Appearance

White, egg-shaped film-coated tablets

Package unit

Bottle - 100 tablets/bottle, Bottle - 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.